Federal oversight of infusion pumps stepped up by Obama Administration and Food and Drug Administration.

摘要

In April, the US Food and Drug Administration (FDA) announced that it was moving to tighten its oversight of medical devices, specifically adopting stricter rules for, manufacturers of automated infusion pumps. Infusion pumps have been viewed as contributing to improvements in patient care, allowing for control, accuracy, and precision in drug and fluid delivery. However, they have also been viewed as one of the most ubiquitous and problematic pieces of medical equipment.